In a recent study, Arasanz et al. showed a possible role of circulating LDNs in the development of resistance to PD-1/PDL1 immunotherapy in non-small-cell lung cancer (NSCLC) patients [83]. The gene discussed is CD274; the disease is non-small cell lung carcinoma.